Non-immune acquired haemolytic anaemias. Dr.Maysem

Similar documents
HEME 10 Bleeding Disorders

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL

What is meant by Thrombotic Microangiopathy (TMA)?

HAEMOLYTIC ANAEMIA. Dr. Hasan Fahmawi, MRCP(London), FRCP(Edin) Consultant Physician

3 Ruba hussein Dr. ahmad Dr. ahmad

Approccio morfologico alle microangiopatie trombotiche

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Peripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital

* Renal insufficiencies

Haemolytic anaemias. Dr. J Potgieter Department of Haematology NHLS Tshwane Academic Division

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL

Some renal vascular disorders

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Pathology note 8 BLEEDING DISORDER

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Platelet Disorders. By : Saja Al-Oran

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

Haemostasis & Coagulation disorders Objectives:

Soliris (eculizumab) DRUG.00050

Hemolytic uremic syndrome: Investigations and management

Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital

Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura

Contents SECTION 1: PHYSIOLOGY OF BLOOD

R. Coward has documented that he has received cooperative grants from Takeda and Novo Nordisk

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

HEMOLYTIC ANEMIA Anemia of increased destruction Normochromic, normochromic anemia Shortened RBC survival Reticulocytosis - Response to increased RBC

Sysmex Educational Enhancement and Development No

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY HEMOLYTIC ANEMIAS. Dr. Tariq Aladily

LAMA SHATAT TTP, ITP, DIC

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis).

Paroxysmal Nocturnal Hemoglobinuria

Approach to Hemolysis

Thrombosis and emboli. Peter Nagy

Dana Alsulaibi. - Ahmad Almuhtaseb. - Tariq Al - Adaily

The importance of thrombocytopenia and its causes

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department

Thrombotic thrombocytopenic purpura: a look at the future

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

Renal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College

Fußzeile (Titel der Präsentation) 1. Thrombotic Microangiopathy: The German Experience 4. Conflictof interest: none

Blood Cell Identification Graded

Anaemia / SCD/ Bleeding disorders in Children

HAEMORRHAGIA Bleeding

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

Heme (Bleeding and Coagulopathies) in the ICU

Bleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following:

BBTS Advanced Clinical and laboratory case studies. Therese Callaghan

HEMODYNAMIC DISORDERS

Primary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes:

Presentation Outline. Disease Background Previous research on platelet recovery rate Goal of our study Methods Results Limitations Conclusions

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type.

Thrombosis. Dr. László Terézia

RBCs Disorders 2. Dr. Nabila Hamdi MD, PhD

eculizumab, 300mg concentrate for solution for infusion (Soliris ) SMC No. (436/07) Alexion Pharma UK Ltd

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

Year 2004 Paper one: Questions supplied by Megan

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.

Specialised Services Policy: CP98 Eculizumab for Atypical Haemolytic Uraemic Syndrome (ahus)

Red Cell Nomenclature

PNH PNH PNH 3/22/2016 PNH. Paroxysmal Nocturnal Hemoglobinuria (PNH): Current Thinking on the Disease PATHOGENESIS OF PNH

Diagnostic Approach to Patients with Anemia

Clinical & Laboratory Assessment

Hemolytic Anemia. Hemolytic Anemia Classification Intracorpuscular Defects. Hemolytic Anemia Classification

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent)

Role of Morphology in the Era of Advanced Cellular Analysis. Barbara J Bain

What is PNH? PNH: What it is Not 9/11/2015. What is Paroxysmal Nocturnal Hemoglobinuria?

DIC. Bert Vandewiele Fellow Critical Care 23 May 2011

There are two main causes of a low platelet count

VPBS-02 Participants Identification No. % Evaluation

Not So Benign Hematology Aplastic anemia, Paroxysmal Nocturnal Hemoglobinuria, atypical Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura

Disorders of Blood Cells & Blood Coagulation

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

General Characterisctics

HEMOLY L TIC AN A EMIA

HAEMORRHAGIA Bleeding

Index. Note: Page numbers of article numbers are in boldface type.

CASE REPORT Assessing donor chimerism using flow cytometry in paroxysmal nocturnal haemoglobinuria after stem cell transplantation - a case report

Thrombotic Microangiopathies

New insights in thrombotic microangiopathies : TTP and ahus

PNH. PNH A study case 5/9/2012. PNH Current Thinking on the Disease, Diagnosis, and Treatment. Where have we been, where are we going?

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP)

Soliris. Soliris (eculizumab) Description

Effect of under filling tube

Haemolytic uraemic syndrome the story of a whodunit

Blood products and plasma substitutes

Hemostatic System - general information

RBCs Disorders 2. Dr. Nabila Hamdi MD, PhD

Bleeding Disorders HOPE Maram Al-anbar

Transcription:

Non-immune acquired haemolytic anaemias Dr.Maysem

Causes of Non-immune acquired haemolytic anaemias.

Infections Infections can cause haemolysis in a variety of ways: -They may precipitate an acute haemolytic crisis in G6PD deficiency -cause microangiopathic haemolytic anaemia (e.g. with meningococcal or pneumococcal septicaemia).. - -

- Malaria causes haemolysis by extravascular destruction of parasitized red cells as well as by direct intravascular lysis. Blackwater fever is an acute intravascular haemolysis accompanied by acute renal failure caused by Falciparum malaria

-Clostridium perfringens septicaemia can cause intravascular haemolysis with marked microspherocytosis - In haemophagocytic syndrome destruction of red cells and their precursors in the marrow, spleen or liver and is associated with amarked rise in LDH.

Chemical and physical agents -Certain drugs (e.g. dapsone and sulfasalazine) in high doses cause oxidative intravascular haemolysis with Heinz body formation in normal subjects. -In Wilson s disease an acute haemolytic anaemia can occur as a result of high levels of copper in the blood. -Chemical poisoning (e.g. with lead, chlorate or arsine) can cause severe haemolysis..

-Severe burns damage red cells causing acanthocytosis or spherocytosis. -Normal red cells when heated in vitro to 46 C for 1 hour show no changes, however they show temperature- and duration dependent changes above 47 50 C.

Fragmentation haemolysis: mechanical haemolytic anaemias These arise through physical damage to red cells either on abnormal surfaces (e.g. artificial heart valves or arterial grafts), arteriovenous malformations or as a microangiopathic haemolytic anaemia.

Red cell fragmentation syndromes. -Cardiac haemolysis: -Prosthetic heart valves -Patches, grafts -Perivalvular leaks -Arteriovenous malformations -Microangiopathic: - TTP HUS -Disseminated intravascularcoagulation -Malignant disease -Vasculitis (e.g. polyarteritis nodosa) -Malignant hypertension -Pre eclampsia/hellp -Renal vascular disorders/hellp syndrom -Ciclosporin- -Homograft rejection

Haemolysis associated with cardiac surgery Cardiac haemolytic anaemia was a term coined to describe haemolysis following cardiac surgery that involved the insertion of prosthetic valves, patches or grafts. Mechanical trauma to red blood cells is the primary cause of haemolysis in this setting and is mainly due to increased turbulent flow resulting in excessive shearing forces on the surface of the red cells..

-Secondary physiologic mechanisms include pressure fluctuations, intrinsic abnormalities of the red cell membrane (largely due to fragile, iron poor red cells in iron-deficient patients), interactionwith foreign surfaces and unfavourable flow characteristics of valves

Arteriovenous malformation Fragmentation of red cells may be seen in Kasabach Merritt syndrome, in which platelets are trapped in the vascular network of giant arteriovenous malformations, sometimes with evidence of a consumption coagulopathy. The bleeding disorder that ensues is of greater significance than haemolysis in these patients. A similar pattern is seen in malignant haemangioendothelioma.

Microangiopathic haemolytic anaemias (MAHA) A condition in which intravascular haemolysis with fragmentation of red cells is caused by their destruction in an abnormal microcirculation.

Proof of microangiopathy may be lacking in those not subjected to a post mortem, and MAHA should be considered a clinical syndrome..

The three main pathological lesions that give rise to MAHA are : 1-deposition of fibrin strands, often associated with DIC 2- platelet adherence and aggregation. 3- vasculitis. The vessel abnormalities may be generalized or confined to particular sites or organs.

In most cases, haemolysis is of less consequence than the underlying cause of the microangiopathy, but fragmentation of red cells helps to confirm the diagnosis

The peripheral blood contains many deeply staining red cell fragments

Blood film in microangiopathic haemolytic anaemia (in this patient Gram negative septicaemia). Numerous contracted and deeply staining cells and cell fragments are present

Blood film from a patient with carcinoma and bone marrow metastases. Note fragmentation of red cells, low platelets and leucoerythroblastic changes (circulating nucleated red cell and metamyelocyte)

Thrombotic thrombocytopenic purpura -is an acute syndrome characterized by fever, neurological signs, haemolytic anaemia with fragmented red cells and profound thrombocytopenia. -There is severe deficiency of von Willebrand factor cleaving protease (VWFCP; also known as ADAMTS13) The diagnosis is made on the basis of the clinical presentation and evidence for haemolytic anaemia with fragmentedred cells and thrombocytopenia. It can be confirmed with an assay which confirms low ADAMTS13 level.

-Thrombocytopenia, schistocytes in the blood film and an impressively elevated serum lactate dehydrogenase (LDH) value are sufficient to suggest the diagnosis. -Coagulation tests are normal in contrast to the findings in DIC. ADAMTS13 is absent or severely reduced in plasma.

The destruction of red cells occurs at the site of intravascular occlusions; at post mortem, platelet and fibrin plugs are found in capillaries.

HUS in children has many common features but organ damage is limited to the kidneys. There is also usually diarrhoea and epileptic seizures may occur. Many cases are associated with Escherichia coli infection with the verotoxin 0157 strain or with other organisms, especially Shigella.

March haemoglobinuria Haemoglobinuria following running has been documented for about 100 years. Its origin is mechanical, with destruction of red cells occurring in the feet. It can be cured by wearing soft shoes or running on soft ground.

It is benign except that it may lead to extensive invasive investigations unless recognized. The blood film does not show any red cell fragmentation or consistent abnormality.

Occasionally, haemoglobinuria after running is accompanied by nausea, abdominal cramps and aching legs, and enthusiastic athletes with this condition may exhibit mild splenomegaly and jaundice.

Acquired disorders of the red cell membrane The most common acquired disorder is paroxysmal nocturnal haemoglobinuria (PNH), caused by somatic mutation of the phosphatidylinositol glycan A (PIGA) gene on the X chromosome, which leads to failure to produce the glycosylphosphatidylinositol (GPI) anchor needed to transport and attach many proteins to the red cell membrane..

Intravascular haemolysis occurs through the unchecked action of activated complement.

The lipids of the membrane are in equilibrium with the lipids of the plasma and changes in the ratio of free cholesterol to phospholipids in plasma may affect red cell shape and, in some instances, lead to haemolysis. This is most commonly seen in liver disease.